Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
2 "Seyed Amir Hassan Habibi"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Article image
Disease Course, Survival, and Genetic Heterogeneity in Chorea-Acanthocytosis: A Case Series of 34 Patients
Aida Ghasemi, Elahe Amini, Ahmad Chitsaz, Gholamali Shahidi, Seyed Amir Hassan Habibi, Atieh Jafarabadi Ashtiani, Arezoo Farzi, Vadieh Ghodsinezhad, Afagh Alavi, Mohammad Rohani
J Mov Disord. 2026;19(4):398-408.   Published online July 14, 2026
DOI: https://doi.org/10.14802/jmd.25350
  • 958 View
  • 99 Download
AbstractAbstract PDFSupplementary Material
Objective
To quantify key disease milestones, particularly loss of ambulation and survival, and to describe the VPS13A variant spectrum and clinical heterogeneity in patients with chorea-acanthocytosis (ChA).
Methods
We conducted a cross-sectional study of 34 ChA patients from 24 unrelated families. Whole-exome sequencing identified VPS13A variants in all probands. Clinical and paraclinical data were collected through neurological evaluations and electronic medical records. Patients were classified as either surviving (ambulatory or non-ambulatory) or deceased.
Results
Twenty-one VPS13A variants were identified, including 12 novel variants. Median current age and disease duration were 38.5 years (interquartile range [IQR], 34–43 years) and 8.0 years (IQR, 4–12.25 years), respectively. Loss of ambulation occurred in 26.5% of patients after a median of 10 years (range, 5–16 years) from onset. Kaplan–Meier analysis estimated a median time to loss of ambulation of 16.0 years (95% confidence interval [CI], 8.8–23.2 years), with estimated ambulation probabilities of 87.4% at 6 years and 38.0% at 16 years. Seven patients died after a median disease duration of 10 years (range, 3–17 years). The median survival time was not reached during follow-up; the estimated restricted mean survival time was 16.7 years (95% CI, 14.1–19.3 years). Compulsions co-occurred with obsessions in all cases and were associated with higher rates of suicidal ideation, while insomnia was more frequent in patients without compulsions. Suicide and sepsis were the leading causes of death.
Conclusion
This study defines the natural history of ChA, providing prognostic data on ambulation and survival. The discovery of novel VPS13A variants highlights genetic heterogeneity and supports further investigation into disease mechanisms and therapeutic targets.
Brief communication
Article image
Clinical and Genetic Characterization of Woodhouse-Sakati Syndrome in Iranian Patients: A Case Series
Sepehr Khosravi, Toktam Moosavian, Shadab Salehpour, Seyed Amir Hassan Habibi, Afagh Alavi, Mohammad Rohani
J Mov Disord. 2025;18(3):257-261.   Published online April 16, 2025
DOI: https://doi.org/10.14802/jmd.25043
  • 3,838 View
  • 69 Download
  • 2 Web of Science
  • 2 Crossref
AbstractAbstract PDFSupplementary Material
Objective
Woodhouse-Sakati syndrome (WSS) is a rare autosomal recessive neuroendocrine disorder characterized by a variety of endocrine and neurological manifestations, including extrapyramidal symptoms and intellectual disability.
Methods
This report presents the genetic characterization of five Iranian patients with WSS, including the first Iranian patient to undergo deep brain stimulation (DBS).
Results
We highlight five Iranian patients with mutations in the DCAF17 gene presenting with variable features of WSS, with symptom onset in early adolescence. Whole exome sequencing identified four homozygous variants (c.436delC, c.982-2A>G, c.580C>T, and c.838+1G>A) within the DCAF17 gene in the probands. Patients had variable responses to common therapies, and one patient achieved significant improvement following DBS.
Conclusion
We expand the clinical and genetic heterogeneity among Iranian patients and suggest the c.436delC variant as a founder mutation in the region. We highlight the importance of considering WSS in patients with both neurological and endocrine symptoms and suggest DBS as a potential treatment option.

Citations

Citations to this article as recorded by  
  • Clinical and Molecular Findings in Two Siblings with a Novel Homozygous DCAF17 Frameshift Variant and Review of the Literature: A Case Report
    Simge Tuana Ay Öner, Elif Yılmaz Güleç
    Molecular Syndromology.2026; : 1.     CrossRef
  • Multidisciplinary management of concurrent hypogonadism, diabetes, and hypothyroidism in Woodhouse-Sakati syndrome: a case report and preliminary clinical management experience
    Xiaoyang Shi, Kai Zhang, Junpeng Yang, Ruizhi Zheng, Huijuan Yuan
    Rare Disease and Orphan Drugs Journal.2026;[Epub]     CrossRef

JMD : Journal of Movement Disorders bluesky InBug Facebook X
Close layer
TOP